Tarsons Products Limited
NSE:TARSONS.NS
436.9 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 847.97 | 1,057.21 | 617.89 | 663.18 | 625.66 | 820.52 | 613.19 | 712.49 | 686.28 | 843.1 | 703.42 | 760.44 | 688.73 | 672.98 | 598.57 | 419.08 |
| Cost of Revenue
| 547.92 | 332.16 | 365.04 | 167.7 | 155.64 | 203.39 | 138.01 | 165.63 | 143.51 | 361.63 | 155.82 | 158.97 | 160.16 | 286.58 | 141.76 | 196.93 |
| Gross Profit
| 300.05 | 725.05 | 252.85 | 495.48 | 470.02 | 617.13 | 475.18 | 546.86 | 542.77 | 481.47 | 547.6 | 601.47 | 528.57 | 386.4 | 456.81 | 222.15 |
| Gross Profit Ratio
| 0.354 | 0.686 | 0.409 | 0.747 | 0.751 | 0.752 | 0.775 | 0.768 | 0.791 | 0.571 | 0.778 | 0.791 | 0.767 | 0.574 | 0.763 | 0.53 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 95.63 | 0 | 0 | 0 | 89.84 | 0 | 0 | 9.47 | 65.18 | 0 | 6.95 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 42.96 | 0 | 0 | 0 | 20.45 | 0 | 0 | 17.97 | 20.7 | 0 | 10.25 |
| SG&A
| 222.7 | 266.62 | 124.6 | 143.92 | 91.14 | 138.59 | 124.06 | 132.16 | 82.6 | 110.29 | 75.48 | 76.44 | 27.44 | 85.88 | 60.82 | 17.2 |
| Other Expenses
| 29.07 | 33.77 | 32.37 | 25.98 | 22.63 | 21.72 | 33.55 | 37.13 | 26.94 | -58.16 | 24.64 | 14.46 | 1.71 | -42.51 | 18.11 | 0.26 |
| Operating Expenses
| 222.7 | 545.87 | 124.6 | 338.75 | 340.07 | 307.31 | 280.49 | 288.85 | 292.76 | 76.48 | 269.75 | 264.86 | 204.56 | 47.55 | 184.75 | 132.87 |
| Operating Income
| 77.35 | 212.95 | 128.25 | 182.71 | 129.95 | 331.54 | 228.24 | 295.14 | 250.01 | 370.99 | 277.85 | 336.61 | 324.01 | 338.85 | 272.06 | 89.28 |
| Operating Income Ratio
| 0.091 | 0.201 | 0.208 | 0.276 | 0.208 | 0.404 | 0.372 | 0.414 | 0.364 | 0.44 | 0.395 | 0.443 | 0.47 | 0.504 | 0.455 | 0.213 |
| Total Other Income Expenses Net
| -14.19 | -42.51 | 7.25 | -9.48 | -1.44 | -20.67 | -12.33 | -7.35 | 22.62 | 21.25 | 10.97 | -1.16 | 9.4 | -23.28 | 10.64 | 4.22 |
| Income Before Tax
| 63.16 | 170.44 | 135.5 | 173.23 | 128.51 | 310.87 | 215.91 | 287.79 | 272.63 | 392.24 | 288.82 | 335.45 | 333.41 | 315.57 | 282.7 | 93.5 |
| Income Before Tax Ratio
| 0.074 | 0.161 | 0.219 | 0.261 | 0.205 | 0.379 | 0.352 | 0.404 | 0.397 | 0.465 | 0.411 | 0.441 | 0.484 | 0.469 | 0.472 | 0.223 |
| Income Tax Expense
| 23 | 67.28 | 36.24 | 45.21 | 32.55 | 82.63 | 54.75 | 73.16 | 69.53 | 97.61 | 74.09 | 86.49 | 85.06 | 80 | 72.21 | 23.83 |
| Net Income
| 40.16 | 103.16 | 99.26 | 128.02 | 95.96 | 228.24 | 161.16 | 214.63 | 203.1 | 294.63 | 214.73 | 248.96 | 248.35 | 235.57 | 210.49 | 69.68 |
| Net Income Ratio
| 0.047 | 0.098 | 0.161 | 0.193 | 0.153 | 0.278 | 0.263 | 0.301 | 0.296 | 0.349 | 0.305 | 0.327 | 0.361 | 0.35 | 0.352 | 0.166 |
| EPS
| 0.75 | 1.94 | 1.87 | 2.41 | 1.8 | 4.29 | 3.03 | 4.03 | 3.82 | 5.69 | 4.14 | 4.68 | 4.88 | 4.62 | 4.13 | 1.33 |
| EPS Diluted
| 0.75 | 1.94 | 1.87 | 2.41 | 1.8 | 4.29 | 3.03 | 4.03 | 3.82 | 5.54 | 4.14 | 4.68 | 4.88 | 4.62 | 4.13 | 1.33 |
| EBITDA
| 187.67 | 336.25 | 228.89 | 279.78 | 235.6 | 414.27 | 300.3 | 364.09 | 338.3 | 466.75 | 355.95 | 399.19 | 386.99 | 355.01 | 324.8 | 130.99 |
| EBITDA Ratio
| 0.221 | 0.318 | 0.37 | 0.422 | 0.377 | 0.505 | 0.49 | 0.511 | 0.493 | 0.554 | 0.506 | 0.525 | 0.562 | 0.528 | 0.543 | 0.313 |